Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Colleoni

Showing results (121-130 of 178) with videos related to

Pageof 18
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2010
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancerG Cancello, P Maisonneuve, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohistochemical assayG Curigliano, M Colleoni, G Renne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2014
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapyE Montagna, V Bagnardi, G Viale, et al.
Anticancer Research|February 26, 2004
Hepatic intra-arterial chemotherapy using a percutaneous catheter in pretreated patients with metastatic colorectal carcinomaN Fazio, F Orsi, R F Grasso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2009
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-upM Colleoni, Z Sun, G Martinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2003
Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction: cytotoxic treatment during the surgical phaseM Colleoni, G Curigliano, I Minchella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2012
Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapseG Cancello, P Maisonneuve, N Rotmensz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study GroupM Colleoni, M Bonetti, A S Coates, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 10, 2016
Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatmentV Galimberti, S K Ribeiro Fontana, P Maisonneuve, et al.
Breast Cancer Research and Treatment|June 30, 2009
Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedureE Montagna, G Viale, N Rotmensz, et al.
Pageof 18

Showing results (121-130 of 178) with videos related to

Sort By:
Pageof 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2010
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancerG Cancello, P Maisonneuve, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohistochemical assayG Curigliano, M Colleoni, G Renne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2014
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapyE Montagna, V Bagnardi, G Viale, et al.
Anticancer Research|February 26, 2004
Hepatic intra-arterial chemotherapy using a percutaneous catheter in pretreated patients with metastatic colorectal carcinomaN Fazio, F Orsi, R F Grasso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2009
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-upM Colleoni, Z Sun, G Martinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2003
Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction: cytotoxic treatment during the surgical phaseM Colleoni, G Curigliano, I Minchella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2012
Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapseG Cancello, P Maisonneuve, N Rotmensz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study GroupM Colleoni, M Bonetti, A S Coates, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 10, 2016
Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatmentV Galimberti, S K Ribeiro Fontana, P Maisonneuve, et al.
Breast Cancer Research and Treatment|June 30, 2009
Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedureE Montagna, G Viale, N Rotmensz, et al.
Pageof 18